Cardiol Rev. 2008 Jan-Feb;16(1):23-9.

Platelet inhibitors: what are the data in women?

Source

Division of Cardiovascular Medicine, Department of Medicine, Duke University Medical Center, Durham, North Carolina 27715-7969, USA.

Abstract

Cardiovascular disease is the leading cause of disability and mortality among women in the United States. However, relative to their representation among the overall population of patients presenting with acute coronary syndromes, women have been underrepresented in clinical trials of treatment strategies for acute coronary syndromes. In general, subgroup analyses and meta-analyses of the data from the major treatment trials have demonstrated similar treatment effects among women and men, but questions recently have been raised regarding the role and effect of antiplatelet therapy in the treatment of women. This article will review the use of antiplatelet therapy in women from the perspective of both primary and secondary prevention using as a focus for discussion recent randomized clinical trial data and registry observations of the potential benefits and risks of antiplatelet therapy in women.

PMID:: 18091399; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Blood Thinners - MedlinePlus Health Information

Molecular Biology Databases

ACETYLSALICYLIC ACID - HSDB

Supplemental Content

Related citations

Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analyses. [Arch Intern Med. 2004]
Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analyses.
Hennekens CH, Sacks FM, Tonkin A, Jukema JW, Byington RP, Pitt B, Berry DA, Berry SM, Ford NF, Walker AJ, et al. Arch Intern Med. 2004 Jan 12; 164(1):40-4.
Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials. [JAMA. 2006]
Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials.
Berger JS, Roncaglioni MC, Avanzini F, Pangrazzi I, Tognoni G, Brown DL. JAMA. 2006 Jan 18; 295(3):306-13.
Review Aspirin for the primary prevention of cardiovascular events: an update of the evidence for the U.S. Preventive Services Task Force. [Ann Intern Med. 2009]
Review Aspirin for the primary prevention of cardiovascular events: an update of the evidence for the U.S. Preventive Services Task Force.
Wolff T, Miller T, Ko S. Ann Intern Med. 2009 Mar 17; 150(6):405-10.
Review Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries. [Clin Ther. 2008]
Review Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries.
Motovska Z, Kala P. Clin Ther. 2008; 30 Pt 2:2191-202.
Review Application of U.S. guidelines in other countries: aspirin for the primary prevention of cardiovascular events in Japan. [Am J Med. 2004]
Review Application of U.S. guidelines in other countries: aspirin for the primary prevention of cardiovascular events in Japan.
Morimoto T, Fukui T, Lee TH, Matsui K. Am J Med. 2004 Oct 1; 117(7):459-68.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Recent activity

Clear Turn Off Turn On

Platelet inhibitors: what are the data in women?
Platelet inhibitors: what are the data in women?
Cardiol Rev. 2008 Jan-Feb ;16(1):23-9.

PubMed
Negative appendectomy and imaging accuracy in the Washington State Surgical Care...
Negative appendectomy and imaging accuracy in the Washington State Surgical Care and Outcomes Assessment Program.
Ann Surg. 2008 Oct ;248(4):557-63.

PubMed
Emerging moulds: Fusarium, Scedosporium and Zygomycetes in transplant recipients...
Emerging moulds: Fusarium, Scedosporium and Zygomycetes in transplant recipients.
Curr Opin Infect Dis. 2003 Dec ;16(6):607-12.

PubMed
Court affirms conviction of HIV-positive prostitute.
Court affirms conviction of HIV-positive prostitute.
AIDS Policy Law. 1997 Apr 18 ;12(7):7.

PubMed
Imaging characteristics of metastatic lesions to the cerebellopontine angle.
Imaging characteristics of metastatic lesions to the cerebellopontine angle.
Otol Neurotol. 2008 Sep ;29(6):835-8.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: